Hi Col, Longstock is a highly reliable source and his knowledge in detail of Osiris business and ramification from its inception is amazing. I recall back in 2016 when Temcell was launched in Japan, we, on the Yahoo board thought that royalties would accrue to Osiris. Longstock, although extremely bullish on Osiris was the only one to insist that royalties on Trmcel are paid to Mesoblast only. His enthusiasm for Osiris and now for Mesoblast never cross the borders of honesty. I am a fan!
Novartis countdown, page-29
-
- There are more pages in this discussion • 345 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |